Author

Anna E. Coghill

Moffitt Cancer CenterORCID 0000-0001-7142-7499Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Gita SunejaiD· 2 shared Abdollah DehzangiiD· 1 shared Ashley L. SaraviaiD· 1 shared Beatrice S. KnudseniD· 1 shared Carla ProiettiiD· 1 shared Carly Feldman· 1 shared Cliona M. RooneyiD· 1 shared Cynthia A. LoomisiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Gita SunejaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PathologyLaboratory InvestigationPeer-reviewedSep 24, 2025

Comparison of QuPath and HALO platforms for analysis of the tumor microenvironment in prostate cancer

Wei Zhang, Qin Zhou, Jonathan V. Nguyen…·Beatrice S. Knudsen

This study compares QuPath and HALO for analyzing prostate cancer tumor microenvironment using multiplex immunofluorescence data, finding high concordance and demonstrating QuPath's flexibility.

4 citations

humanimaging

Cancer BiologybioRxivPreprintApr 17, 2025

Population analysis and immunologic landscape of melanoma in people living with HIV indicate impaired antitumor immunity

Lindsay N. Barger, Derek D. Wang, Ashley L. Saravia…·Gabriele Romano

This paper analyzes melanoma in people living with HIV, finding impaired antitumor immunity, delayed ICI treatment, and an immunosuppressive tumor microenvironment.

DOI 10.1101/2025.04.17.648995

humanproteomics

MicrobiologyBlood AdvancesPeer-reviewedFeb 5, 2025

Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy

Yomani D. Sarathkumara, Nathan W Van Bibber, Zhiwei Liu…·Denise L. Doolan

The paper identifies differential EBV protein-specific antibody responses between responders and non-responders to EBVST immunotherapy, suggesting these antibodies could predict clinical outcomes.

2 citations

humanproteomics